Charles Schwab’s Corcept Therapeutics CORT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $101M | Buy |
1,157,580
+37,621
| +3% | +$2.27M | 0.01% | 793 |
|
|
2026
Q1 | $45.1M | Buy |
1,119,959
+57,858
| +5% | +$2.16M | 0.01% | 1234 |
|
|
2025
Q4 | $37M | Sell |
1,062,101
-8,180
| -0.8% | -$643K | 0.01% | 1351 |
|
|
2025
Q3 | $89M | Buy |
1,070,281
+255,826
| +31% | +$18.5M | 0.01% | 785 |
|
|
2025
Q2 | $59.8M | Sell |
814,455
-217,269
| -21% | -$15.8M | 0.01% | 988 |
|
|
2025
Q1 | $118M | Sell |
1,031,724
-19,836
| -2% | -$1.21M | 0.02% | 577 |
|
|
2024
Q4 | $53M | Buy |
1,051,560
+25,073
| +2% | +$1.31M | 0.01% | 1091 |
|
|
2024
Q3 | $47.5M | Buy |
1,026,487
+53,191
| +5% | +$1.89M | 0.01% | 1157 |
|
|
2024
Q2 | $31.6M | Buy |
973,296
+39,835
| +4% | +$1.09M | 0.01% | 1374 |
|
|
2024
Q1 | $23.5M | Buy |
933,461
+33,017
| +4% | +$780K | 0.01% | 1518 |
|
|
2023
Q4 | $29.2M | Buy |
900,444
+39,111
| +5% | +$1.07M | 0.01% | 1354 |
|
|
2023
Q3 | $23.5M | Buy |
861,333
+17,636
| +2% | +$510K | 0.01% | 1402 |
|
|
2023
Q2 | $18.8M | Sell |
843,697
-46,266
| -5% | -$1.06M | 0.01% | 1546 |
|
|
2023
Q1 | $19.3M | Sell |
889,963
-113
| -0% | -$2.48K | 0.01% | 1503 |
|
|
2022
Q4 | $18.1M | Buy |
890,076
+67,419
| +8% | +$1.69M | 0.01% | 1512 |
|
|
2022
Q3 | $21.1M | Buy |
822,657
+7,465
| +0.9% | +$200K | 0.01% | 1339 |
|
|
2022
Q2 | $19.4M | Buy |
815,192
+29,476
| +4% | +$642K | 0.01% | 1433 |
|
|
2022
Q1 | $17.7M | Buy |
785,716
+105,951
| +16% | +$2.25M | 0.01% | 1643 |
|
|
2021
Q4 | $13.5M | Sell |
679,765
-85,672
| -11% | -$1.74M | ﹤0.01% | 1844 |
|
|
2021
Q3 | $15.1M | Sell |
765,437
-105
| -0% | -$2.2K | ﹤0.01% | 1784 |
|
|
2021
Q2 | $16.8M | Sell |
765,542
-24,867
| -3% | -$553K | 0.01% | 1707 |
|
|
2021
Q1 | $18.8M | Buy |
790,409
+26,454
| +3% | +$706K | 0.01% | 1577 |
|
|
2020
Q4 | $20M | Buy |
763,955
+14,173
| +2% | +$299K | 0.01% | 1411 |
|
|
2020
Q3 | $13.1M | Sell |
749,782
-16,076
| -2% | -$256K | 0.01% | 1500 |
|
|
2020
Q2 | $12.9M | Buy |
765,858
+74,478
| +11% | +$1.05M | 0.01% | 1475 |
|
|
2020
Q1 | $8.22M | Buy |
691,380
+4,408
| +0.6% | +$54.5K | ﹤0.01% | 1570 |
|
|
2019
Q4 | $8.31M | Buy |
686,972
+86,617
| +14% | +$1.21M | ﹤0.01% | 1747 |
|
|
2019
Q3 | $8.49M | Buy |
600,355
+8,056
| +1% | +$99K | 0.01% | 1698 |
|
|
2019
Q2 | $6.61M | Buy |
592,299
+10,780
| +2% | +$120K | ﹤0.01% | 1837 |
|
|
2019
Q1 | $6.83M | Buy |
581,519
+19,250
| +3% | +$239K | ﹤0.01% | 1822 |
|
|
2018
Q4 | $7.51M | Buy |
562,269
+56
| +0% | +$740 | 0.01% | 1652 |
|
|
2018
Q3 | $7.88M | Buy |
562,213
+60,276
| +12% | +$842K | 0.01% | 1790 |
|
|
2018
Q2 | $7.89M | Buy |
501,937
+11,274
| +2% | +$196K | 0.01% | 1750 |
|
|
2018
Q1 | $8.07M | Buy |
490,663
+9,739
| +2% | +$180K | 0.01% | 1649 |
|
|
2017
Q4 | $8.69M | Buy |
480,924
+66,749
| +16% | +$1.21M | 0.01% | 1579 |
|
|
2017
Q3 | $7.99M | Buy |
414,175
+43,602
| +12% | +$650K | 0.01% | 1601 |
|
|
2017
Q2 | $4.37M | Buy |
370,573
+30,591
| +9% | +$333K | ﹤0.01% | 1887 |
|
|
2017
Q1 | $3.73M | Buy |
339,982
+19,527
| +6% | +$172K | ﹤0.01% | 1925 |
|
|
2016
Q4 | $2.33M | Buy |
320,455
+41,054
| +15% | +$322K | ﹤0.01% | 2124 |
|
|
2016
Q3 | $1.82M | Buy |
279,401
+162,495
| +139% | +$945K | ﹤0.01% | 2181 |
|
|
2016
Q2 | $639K | Buy |
116,906
+30,400
| +35% | +$158K | ﹤0.01% | 2506 |
|
|
2016
Q1 | $405K | Hold |
86,506
| – | – | ﹤0.01% | 2662 |
|
|
2015
Q4 | $431K | Hold |
86,506
| – | – | ﹤0.01% | 2715 |
|
|
2015
Q3 | $326K | Hold |
86,506
| – | – | ﹤0.01% | 2793 |
|
|
2015
Q2 | $520K | Buy |
86,506
+18,106
| +26% | +$111K | ﹤0.01% | 2662 |
|
|
2015
Q1 | $384K | Hold |
68,400
| – | – | ﹤0.01% | 2737 |
|
|
2014
Q4 | $206K | Hold |
68,400
| – | – | ﹤0.01% | 2973 |
|
|
2014
Q3 | $184K | Hold |
68,400
| – | – | ﹤0.01% | 2971 |
|
|
2014
Q2 | $192K | Hold |
68,400
| – | – | ﹤0.01% | 3005 |
|
|
2014
Q1 | $299K | Hold |
68,400
| – | – | ﹤0.01% | 2804 |
|
|
2013
Q4 | $221K | Hold |
68,400
| – | – | ﹤0.01% | 2930 |
|
|
2013
Q3 | $111K | Hold |
68,400
| – | – | ﹤0.01% | 3024 |
|
|
2013
Q2 | $122K | Buy |
+68,400
| New | +$123K | ﹤0.01% | 3007 |
|
Other funds holding CORT
ISL
PA
Charles Schwab's CORT Position: Q2 2026 in Review
Charles Schwab increased its Corcept Therapeutics (CORT) stake by 3.4% in Q2 2026, buying an estimated $2.27M and bringing the position to 1,157,580 shares worth $101M. The position accounts for 0.01% of the portfolio, ranked #793.
Charles Schwab first reported a position in CORT in Q2 2013 and has held it in 53 quarters since. The position peaked at $118M in Q1 2025. 422 funds tracked by Wall St. Rank hold CORT as of Q2 2026.
- Charles Schwab held 1,157,580 shares of Corcept Therapeutics worth $101M as of Q2 2026.
- Charles Schwab bought 37,621 Corcept Therapeutics shares in Q2 2026, an estimated $2.27M.
- Corcept Therapeutics made up 0.01% of Charles Schwab's portfolio in Q2 2026, its #793 holding.
- Charles Schwab first reported a position in Corcept Therapeutics in Q2 2013 and has held it in 53 quarters since.
- Charles Schwab's Corcept Therapeutics position peaked at $118M in Q1 2025.
- 422 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q2 2026.
Based on Charles Schwab's 13F filing for Q2 2026, filed 14 Aug 2026.